Compare Abbott Laboratories (ABT) vs Eos Energy Enterprises Inc (EOSE) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Eos Energy Enterprises Inc — how do they compare? Abbott Laboratories trades at $95.42 (market cap $166.94B), while Eos Energy Enterprises Inc trades at $4.48 (market cap $1.68B). The key difference: Abbott Laboratories is far larger — about 99.4× Eos Energy Enterprises Inc's market cap, and Abbott Laboratories pays a 2.63% dividend while Eos Energy Enterprises Inc pays none. Which is the better fit depends on your goals.
| ABT | EOSE | |
|---|---|---|
Market Cap | $166.94B | $1.68B |
Sector | Health | Energy |
52-Week High | $136.62 | $19.19 |
52-Week Low | $82.57 | $4.40 |
Enterprise Value | $193.69B | $1.91B |
Dividend Yield | 2.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
EOSE trades at $5.06, down 3.25% today, amid a bearish technical signal despite a recent Q1 2026 earnings beat. The company shows rapid revenue growth but deep losses, with a net income margin of -296.13% in 2026. Recent news highlights progress in its Frontier Power USA venture and new supply agreements, yet cash flow remains negative from operations, relying on financing.
The outlook is mixed: analyst consensus is a Buy with a $8.33 price target, signaling potential upside, but high execution risk persists given substantial losses and a debt-to-asset ratio of 91.87%. Investors face volatility from operational cash burn against growth initiatives in the competitive energy storage market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Eos Energy Enterprises Inc
Eos Energy Enterprises provides long-duration energy storage solutions. Its signature zinc-based batteries are designed for utility-scale applications, helping to stabilize power grids and integrate renewable energy.
Read more on EOSE →
